As of 2025-05-16, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.31) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -2162.7%.
The range of the Relative Valuation is (0.15) - (0.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 4.6x | 2.8x |
| Forward P/E multiples | 0.8x - 3.2x | 2.0x |
| Fair Price | (0.15) - (0.41) | (0.31) |
| Upside | -1069.7% - -2821.9% | -2162.7% |
| Date | P/E |
| 2025-05-06 | -0.08 |
| 2025-04-01 | -0.12 |
| 2025-03-28 | -0.12 |
| 2025-03-24 | -0.12 |
| 2025-03-20 | -0.16 |
| 2025-03-18 | -0.16 |
| 2025-03-11 | -0.12 |